Aytu BioPharma Inc (LTS:0A8M)
$ 1.59 -0.01 (-0.62%) Market Cap: 9.90 Mil Enterprise Value: 6.35 Mil PE Ratio: 0 PB Ratio: 0.33 GF Score: 40/100

Q3 2019 Aytu BioScience Inc Earnings Call Transcript

May 14, 2019 / 01:00PM GMT
Operator

Good morning, everyone. Thank you for joining us for the Aytu BioScience Third Quarter Fiscal 2019 Business Update call. With me this morning are Aytu's Chief Executive Officer, Josh Disbrow; Chief Financial Officer, Dave Green; and Chief Operating Officer, Jarrett Disbrow.

Aytu BioScience issued a press release earlier this morning with details of the company's operational and financial results. A copy of the press release is available on the news page of the company's website at aytubio.com. I'd like to remind everyone that today's conference is being recorded. (Operator Instructions) In addition, an archived webcast replay will be available on the company's investor page under Events and Presentations at aytubio.com following the conclusion of this conference call.

I'd also like to call your attention to the customary safe harbor disclosure regarding forward-looking information. The conference call today will contain certain forward-looking statements, including statements regarding the goals, strategies, beliefs, expectations and future potential operating results of Aytu BioScience.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot